People In The News – Tracking The Latest Industry Personnel Moves
Executive Summary
Pfizer elects current President and CEO Read chairman of the board; Former FDA Commissioner von Eschenbach joins BioTime board of directors; new leadership at Theraclone Sciences, DVS Sciences and Emerald BioStructures. More personnel announcements in this month’s column.
You may also be interested in...
Gilead Springs Further Into Oncology With Calistoga Acquisition
Dominant in HIV, the biotech pays $375 million up front for Seattle-based Calistoga and its closely-watched PI3K program.
Pfizer Turns To Insider Ian Read To See It Into Post-Lipitor Era
The 32-year Pfizer veteran will take over for Jeffrey Kindler in a succession viewed as a surprise by Wall Street.
FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees
Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.